Mutational analysis of JAK2V617F in tunisian polycythemia vera patients

被引：0
|
作者：
Frikha, R. [2 ]
Elloumi, M. [1 ]
Kamoun, H. [2 ]
机构：
[1] Hosp Hedi Chaker Sfax, Dept Hematol, Sfax, Tunisia
[2] Hosp Hedi Chaker Sfax, Dept Med Genet, Sfax, Tunisia
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.118357
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P0786
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Detection of JAK2V617F used for diagnosis of polycythemia vera and correlation with other biomarkers
    Daniels, L.
    Vermeulen, K.
    Van De Velde, A. L.
    Vrelust, I.
    Gadisseur, A. P.
    Schroyens, W.
    Berneman, Z. N.
    ACTA CLINICA BELGICA, 2007, 62 (04): : 262 - 262
  • [32] THROMBOSIS IN POLYCYTHEMIA VERA ARE LIKELY TO BE RELATED TO HIGHER JAK2V617F ALLELE BURDEN
    Bertozzi, I.
    Scapin, M.
    Tezza, F.
    Scandellari, R.
    Fabris, F.
    Randi, M. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 361 - 361
  • [33] Monocyte (MNC) hemostatic profile in essential thrombocythemia (ET) or polycythemia vera (PV) patients is influenced by JAK2V617F mutational load
    Vignoli, A.
    Marchetti, M.
    Russo, L.
    Panova-Noeva, M.
    Salmoiraghi, S.
    Barbui, T.
    Rambaldi, A.
    ten Cate, H.
    Falanga, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 49 - 49
  • [34] JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib
    Pieri, Lisa
    Pancrazzi, Alessandro
    Pacilli, Annalisa
    Rabuzzi, Claudia
    Rotunno, Giada
    Fanelli, Tiziana
    Guglielmelli, Paola
    Fjerza, Rajmonda
    Paoli, Chiara
    Verstovsek, Srdan
    Vannucchi, Alessandro M.
    BLOOD, 2015, 125 (21) : 3352 - 3353
  • [35] Hematopoietic Clonal Dominance and Evolutionary Pattern Of JAK2V617F Allele Burden In Polycythemia Vera Patients
    Angona, Anna
    Alvarez-Larran, Alberto
    Bellosillo, Beatriz
    Martinez-Aviles, Luz
    Camacho, Laura
    Fernandez-Rodrrguez, Concepcion
    Pairet, Silvia
    Longaron, Raquel
    Ancochea, Agueda
    Besses, Carlos
    BLOOD, 2013, 122 (21)
  • [36] Enhanced calreticulin expression in red cells of polycythemia vera patients harboring the JAK2V617F mutation
    Brusson, Megane
    Cochet, Sylvie
    Leduc, Marjorie
    Guillonneau, Francois
    Mayeux, Patrick
    Peyrard, Thierry
    Chomienne, Christine
    Le Van Kim, Caroline
    Cassinat, Bruno
    Kiladjian, Jean-Jacques
    El Nemer, Wassim
    HAEMATOLOGICA, 2017, 102 (07) : E241 - E244
  • [37] Decrease in JAK2V617F Allele Burden is Not a Prerequisite to Clinical Response in Patients with Polycythemia Vera (PV).
    Silver, Richard T.
    Vandris, Katherine
    Goldman, Joshua J.
    Adriano, Fernando
    Wang, Y. Lynn
    Jones, Amy V.
    Christos, Paul J.
    Cross, N. C. P.
    BLOOD, 2009, 114 (22) : 757 - 758
  • [38] Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera
    Swierczek, Sabina I.
    Yoon, Donghoon
    Bellanne-Chantelot, Christine
    Kim, Soo Jin
    Saint-Martin, Cecile
    Delhommeau, Francois
    Najman, Albert
    Prchal, Josef T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (05): : 775 - 778
  • [39] JAK2V617F allele burden and thrombosis: A direct comparison in essential thrombocythemia and polycythemia vera
    Carobbio, Alessandra
    Finazzi, Guido
    Antonioli, Elisabetta
    Guglielmelli, Paola
    Vannucchi, Alessandro M.
    Dellacasa, Chiara M.
    Salmoiraghi, Silvia
    Delaini, Federica
    Rambaldi, Alessandro
    Barbui, Tiziano
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (09) : 1016 - 1021
  • [40] The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera
    Tefferi, A
    Lasho, TL
    Schwager, SM
    Strand, JS
    Elliott, M
    Mesa, R
    Li, CY
    Wadleigh, M
    Lee, SJ
    Gilliland, DG
    CANCER, 2006, 106 (03) : 631 - 635
12345